HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First Quarter ended June 30, 2012 on Thursday, July 19, 2012 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com.
Summary of Events
|Event||Date and Time (IST)||Medium|
|Release of financial results||July 19, after the Board Meeting||
Email, Media, Company website, Business Wire
|Earnings Call||July 19, 6.30 PM IST / 9:00 AM EST||
Hosted by the Company
|Webcast of Earnings Call||July 19, 6.30 PM IST / 9.00 AM EST through July 24, 2012||
URL available on Company’s website,
|Transcripts of the Earnings call||Will be available on the Company’s website||
URL available on Company’s website, www.drreddys.com
Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.
|Conference Dial-In Numbers|
|Primary Number:||+91 22 3065 0136|
|Secondary Number:||+91 22 6629 0356|
|The numbers listed above are universally accessible from all networks and all countries.|
|Local Access Number:||
Available in - Gurgaon (NCR), Bangalore, Kolkata, Cochin, Pune,
Accessible from all carriers.
|International Toll Free Number:||
USA: 1 866 746 2133
UK: 0 808 101 1573
Singapore: 800 101 2045
Hong Kong: 800 964 448
No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.
The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through July 24, 2012. For play back dial in phone No: 022 3065 1212 and ID: 375#.
The transcript of the earnings call will also be available on the Company's website.
About Dr. Reddy’s
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs. Therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management, anti-infective and pediatrics. Major markets include India, USA, Russia and CIS, Germany, UK, Venezuela, S. Africa, Romania, and New Zealand. For more information, log on to: www.drreddys.com